Pfizer-BioNTech vaccine for children under 5 could be available by end of February: Report
Children vaccination: Covid-19 vaccines for children younger than 5 could be available as soon as end-February under a plan that would lead to the potential authorization of a two-shot regimen in the coming weeks
After Pfizer, Moderna starts trial of Omicron-specific Covid vaccine
US drug maker Moderna has started trial of a Covid booster vaccine that specifically targets the Omicron variant, the company has announced. Moderna starts trial for Omicron-specific booster shot, follows Pfizer
The coronavirus variant has quickly become dominant in many parts of the world, driving up infections and straining healthcare systems.
Pfizer begins testing omicron-matched Covid-19 shots in adults
Pfizer and its partner BioNTech announced the study on Tuesday
Current Covid vaccines may protect from disease caused by Omicron: Study
Current COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 that can recognise variants of concern, including Omicron, and protect from severe disease, a study has found. The research, published in the journal Cell, also shows that fully vaccinated people have fewer memory B cells and neutralising antibodies against the Omicron variant. Both T and B cells play an important role in the immune response against an infection. Scientists at La Jolla Institute for Immunology (LJI) in the US tested four COVID-19 vaccines -- Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax. "The vast majority of T cell responses are still effective against Omicron," said study co-leader Alessandro Sette, a professor at LJI. "These cells won't stop you from getting infected, but in many cases they are likely to keep you from getting very ill," said co-author Shane Crotty, a professor at LJI. This is true in all the type of vaccines studied, and up to six months .
PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting For Consideration And To Take On Record The Unaudited Financial Results For The Quarter Ended December 31, 2021.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 3, 2022, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2021. Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company was closed from Friday, December 31, 2021 (close of business) till 48 hours after the results are made public on February 3, 2022. We request you to kindly take the same on record.
COVID-19: Annual vaccine preferred to frequent boosters, says Pfizer CEO
In an interview with Israel's N12 News, Bourla was asked whether he sees booster shots being administered every four to five months on a regular basis. Covid-19 pandemic: WHO panel for use of Pfizer jab on 5-11-year olds
The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Wednesday
Pfizer's new Covid-19 pill works against Omicron in lab
Three separate, unpublished lab studies indicate Paxlovid is effective against the variant despite its mutations
Hyderabad's Biophore to manufacture ingredients of Pfizer's Covid drug
Biophore India Pharmaceutical announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy